Prevalence and predictors of persistent sinus rhythm after elective electrical cardioversion for atrial fibrillation
- PMID: 33882536
- DOI: 10.2459/JCM.0000000000001182
Prevalence and predictors of persistent sinus rhythm after elective electrical cardioversion for atrial fibrillation
Abstract
Aims: To evaluate the prevalence and predictors of persistent sinus rhythm in a recent cohort of unselected patients undergoing electrical cardioversion for atrial fibrillation.
Methods: We enrolled all consecutive patients undergoing elective electrical cardioversion for atrial fibrillation between January 2017 and December 2018. We analysed baseline clinical and echocardiographic data as well as pharmacological antiarrhythmic therapy. Primary endpoint was the maintenance of sinus rhythm at 12 months after electrical cardioversion.
Results: Of the 300 patients enrolled, 270 (90%) had successful electrical cardioversion and among them, 201 patients have 12-month follow-up data (mean age 70 ± 10 years; 74% men). At 12 months, only 45.7% were in sinus rhythm. Patients without sinus rhythm compared with persistent sinus rhythm at 12 months had a lower baseline left ventricle ejection fraction (LVEF) (49.1 ± 16 vs. 59.7 ± 9%, P = 0.02) and had more frequently a history of atrial fibrillation more than 12 months (55 vs. 34% P = 0.003). At the multivariate analysis, only the duration of the disease beyond 12 months (OR 0.26, 95% CI: 0.08-0.88, P = 0.032), LVEF (OR 1.06, 95% CI: 1.01-1.12, P = 0.012) and the presence of sinus rhythm at 1-month follow-up (OR 18.28, 95% CI: 3.3-100, P = 0.001) were associated with the probability of maintaining sinus rhythm at 12 months.
Conclusion: In unselected patients with atrial fibrillation undergoing elective electrical cardioversion, only 45.7% were in sinus rhythm at 12 months. The presence of sinus rhythm at 1-month follow-up emerged as an independent predictor of maintenance of sinus rhythm. This highlights that early re-evaluation of these patients appears useful for assessing longer term outcomes also from the perspective of a possible selective approach to ablation strategies.
Copyright © 2021 Italian Federation of Cardiology - I.F.C. All rights reserved.
Similar articles
-
Success of serial external electrical cardioversion of persistent atrial fibrillation in maintaining sinus rhythm; a randomized study.Eur Heart J. 2002 Oct;23(19):1522-8. doi: 10.1053/euhj.2002.3167. Eur Heart J. 2002. PMID: 12242072 Clinical Trial.
-
Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation.Clin Cardiol. 2001 Mar;24(3):238-44. doi: 10.1002/clc.4960240313. Clin Cardiol. 2001. PMID: 11288971 Free PMC article.
-
Echocardiographic assessment of left atrial morphology and function to predict maintenance of sinus rhythm after electrical cardioversion in patients with non-valvular persistent atrial fibrillation and normal function or mild dysfunction of left ventricle.Cardiol J. 2020;27(3):246-253. doi: 10.5603/CJ.a2019.0068. Epub 2019 Jul 17. Cardiol J. 2020. PMID: 31313277 Free PMC article.
-
A review of factors associated with maintenance of sinus rhythm after elective electrical cardioversion for atrial fibrillation.Clin Cardiol. 2018 Jun;41(6):862-870. doi: 10.1002/clc.22931. Epub 2018 Jun 7. Clin Cardiol. 2018. PMID: 29878481 Free PMC article. Review.
-
[Electrical and pharmacological strategies for early cardioversion of atrial fibrillation].Herzschrittmacherther Elektrophysiol. 2006 Jun;17(2):81-8. doi: 10.1007/s00399-006-0514-0. Herzschrittmacherther Elektrophysiol. 2006. PMID: 16786466 Review. German.
Cited by
-
Body surface mapping of P-waves in sinus rhythm to predict recurrence following cardioversion for atrial fibrillation.Front Cardiovasc Med. 2024 Jul 25;11:1417029. doi: 10.3389/fcvm.2024.1417029. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39119182 Free PMC article.
-
Safety and efficacy of a nurse-led elective cardioversion with etomidate for atrial arrhythmia in a tertiary hospital.Heliyon. 2023 Apr 4;9(4):e15158. doi: 10.1016/j.heliyon.2023.e15158. eCollection 2023 Apr. Heliyon. 2023. PMID: 37089358 Free PMC article.
-
Predicting the Outcomes of External Direct Current Cardioversion for Atrial Fibrillation: A Narrative Review of Current Evidence.J Cardiovasc Dev Dis. 2025 Apr 25;12(5):168. doi: 10.3390/jcdd12050168. J Cardiovasc Dev Dis. 2025. PMID: 40422939 Free PMC article. Review.
References
-
- Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285:2370–2375.
-
- Roger VL, Go AS, Lloyd-Jones DM, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 2012; 125:188–197.
-
- Di Giosia P, Giorgini P, Ferri C. Considerations on stroke in atrial fibrillation despite anticoagulation. J Cardiovasc Med (Hagerstown) 2018; 19: (Suppl 1): e54–e57.
-
- Genovesi-Ebert A, Sorini-Dini C, Di Fusco SA, Imperoli G, Colivicchi F. Is the risk of stroke in permanent and paroxysmal atrial fibrillation really the same? Therein lies the dilemma. J Cardiovasc Med (Hagerstown) 2020; 21:540–546.
-
- Nuzzi V, Cannatà A, Manca P, et al. Atrial fibrillation in dilated cardiomyopathy: outcome prediction from an observational registry. Int J Cardiol 2020; 323:140–147.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical